BSV is known for its unique qualitative as well as quantitative, state-of-the-art approach to evaluating assets.  In the past it has supported major, multinational pharmaceutical companies in the implementation of value-driven global project and portfolio management, private US biotech firms in fundraising, European pharmaceutical companies in creating spin-offs and public US biotech companies in strategic repositioning.  BSV has access to a network of clients in Europe, the USA and in India.

Bioscience Valuation’s affiliate, Bioscience Market Research, supplies complementary primary and secondary market research with the goal of reducing commercial risk early on in a project's R&D cycle when product profiles can still be modified. Its assignments include the investigation of physicians' preferences regarding innovative drugs and therapies for human and animal health.

The scientific and financial backgrounds as well as broad experience of the teams at BSV and its affiliates ensure optimal support with the ultimate goal of helping our clients achieve maximum returns on their assets.